{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:35:17Z","timestamp":1789785317949,"version":"4.0.1"},"reference-count":53,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81000922, 81470548"],"award-info":[{"award-number":["81000922, 81470548"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G1001141"],"award-info":[{"award-number":["G1001141"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"publisher","award":["2016JZ029"],"award-info":[{"award-number":["2016JZ029"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01602","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T10:58:42Z","timestamp":1511175522000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Complement Receptor 3 Has Negative Impact on Tumor Surveillance through Suppression of Natural Killer Cell Function"],"prefix":"10.3389","volume":"8","author":[{"given":"Cheng-Fei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yun","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naiyin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Xing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiju","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuding","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,11,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/ni0508-477","article-title":"Natural killer cell recognition of missing self","volume":"9","author":"Karre","year":"2008","journal-title":"Nat Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev.immunol.24.021605.090700","article-title":"Natural killer cell developmental pathways: a question of balance","volume":"24","author":"Di Santo","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","article-title":"NK cell recognition","volume":"23","author":"Lanier","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.it.2013.01.003","article-title":"Activating natural cytotoxicity receptors of natural killer cells in cancer and infection","volume":"34","author":"Koch","year":"2013","journal-title":"Trends Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/82_2015_446","article-title":"NK cells and cancer immunoediting","volume":"395","author":"Guillerey","year":"2016","journal-title":"Curr Top Microbiol Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00262-013-1469-8","article-title":"Advantages and clinical applications of natural killer cells in cancer immunotherapy","volume":"63","author":"Ames","year":"2014","journal-title":"Cancer Immunol Immunother"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1172\/JCI36022","article-title":"NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo","volume":"119","author":"Lakshmikanth","year":"2009","journal-title":"J Clin Invest"},{"key":"B9","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1158\/0008-5472.can-12-0509","article-title":"NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases","volume":"72","author":"Chow","year":"2012","journal-title":"Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nature12998","article-title":"The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells","volume":"507","author":"Paolino","year":"2014","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P","article-title":"The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma","volume":"79","author":"Coca","year":"1997","journal-title":"Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<577::AID-CNCR13>3.0.CO;2-V","article-title":"Prognostic value of intratumoral natural killer cells in gastric carcinoma","volume":"88","author":"Ishigami","year":"2000","journal-title":"Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1158\/2159-8290.cd-13-0985","article-title":"T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapy","volume":"4","author":"Melero","year":"2014","journal-title":"Cancer Discov"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e89829","DOI":"10.1172\/jci.insight.89829","article-title":"The head and neck cancer immune landscape and its immunotherapeutic implications","volume":"1","author":"Mandal","year":"2016","journal-title":"JCI Insight"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1182\/blood-2010-08-264085","article-title":"Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation","volume":"117","author":"Moretta","year":"2011","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1182\/blood-2011-01-329508","article-title":"Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients","volume":"118","author":"Curti","year":"2011","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/ni.3518","article-title":"Targeting natural killer cells in cancer immunotherapy","volume":"17","author":"Guillerey","year":"2016","journal-title":"Nat Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/eji.201344272","article-title":"Effect of tumor cells and tumor microenvironment on NK-cell function","volume":"44","author":"Vitale","year":"2014","journal-title":"Eur J Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1158\/0008-5472.can-11-3873","article-title":"Primary tumor hypoxia recruits CD11b+\/Ly6Cmed\/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche","volume":"72","author":"Sceneay","year":"2012","journal-title":"Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/bmt.2009.265","article-title":"Early evaluation of natural killer activity in post-transplant acute myeloid leukemia patients","volume":"45","author":"Pittari","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"B22","doi-asserted-by":"publisher","first-page":"6287","DOI":"10.1158\/1078-0432.CCR-11-1347","article-title":"Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression","volume":"17","author":"Parkhurst","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5084","DOI":"10.1182\/blood-2008-05-156646","article-title":"Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation","volume":"112","author":"Li","year":"2008","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.4049\/jimmunol.0804186","article-title":"Dendritic cell function in allostimulation is modulated by C5aR signaling","volume":"183","author":"Peng","year":"2009","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1016\/j.molimm.2009.05.181","article-title":"Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions","volume":"46","author":"Erdei","year":"2009","journal-title":"Mol Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"10680","DOI":"10.1073\/pnas.91.22.10680","article-title":"Identification of the complement iC3b binding site in the beta 2 integrin CR3 (CD11b\/CD18)","volume":"91","author":"Ueda","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B28","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/eji.200838951","article-title":"iC3b-opsonized apoptotic cells mediate a distinct anti-inflammatory response and transcriptional NF-kappaB-dependent blockade","volume":"40","author":"Amarilyo","year":"2010","journal-title":"Eur J Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00262-005-0690-5","article-title":"Release of iC3b from apoptotic tumor cells induces tolerance by binding to immature dendritic cells in vitro and in vivo","volume":"55","author":"Schmidt","year":"2006","journal-title":"Cancer Immunol Immunother"},{"key":"B30","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nm814","article-title":"Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells","volume":"9","author":"Sohn","year":"2003","journal-title":"Nat Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/CJI.0b013e3181bed29f","article-title":"Soluble iC3b as an early marker for pancreatic adenocarcinoma is superior to CA19.9 and radiology","volume":"33","author":"Marten","year":"2010","journal-title":"J Immunother"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/ni.1787","article-title":"The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development","volume":"10","author":"Gascoyne","year":"2009","journal-title":"Nat Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.4049\/jimmunol.0902844","article-title":"SHIP1 inhibition increases immunoregulatory capacity and triggers apoptosis of hematopoietic cancer cells","volume":"184","author":"Brooks","year":"2010","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/978-1-60761-362-6_22","article-title":"A simple method to measure NK cell cytotoxicity in vivo","volume":"612","author":"Saudemont","year":"2010","journal-title":"Methods Mol Biol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.1038\/onc.2008.267","article-title":"NK cells and cancer immunosurveillance","volume":"27","author":"Waldhauer","year":"2008","journal-title":"Oncogene"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.bcp.2011.05.031","article-title":"Enzymatic and non-enzymatic activities of SHIP-1 in signal transduction and cancer","volume":"82","author":"Conde","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e88544","DOI":"10.1172\/jci.insight.88544","article-title":"A small-molecule inhibitor of SHIP1 reverses age- and diet-associated obesity and metabolic syndrome","volume":"1","author":"Srivastava","year":"2016","journal-title":"JCI Insight"},{"key":"B38","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/978-1-4614-5915-6_11","article-title":"The role of complement in tumor growth","volume":"772","author":"Pio","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/ni.1655","article-title":"Modulation of the antitumor immune response by complement","volume":"9","author":"Markiewski","year":"2008","journal-title":"Nat Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1158\/0008-5472.CAN-14-0157","article-title":"Complement c5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche","volume":"74","author":"Vadrevu","year":"2014","journal-title":"Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1182\/blood-2007-02-074716","article-title":"NK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complement","volume":"111","author":"Wang","year":"2008","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1182\/blood-2009-01-200469","article-title":"Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody therapy in an in vivo model","volume":"114","author":"Wang","year":"2009","journal-title":"Blood"},{"key":"B43","doi-asserted-by":"publisher","first-page":"8004","DOI":"10.4049\/jimmunol.180.12.8004","article-title":"T-bet plays a key role in NK-mediated control of melanoma metastatic disease","volume":"180","author":"Werneck","year":"2008","journal-title":"J Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1016\/j.molimm.2009.05.009","article-title":"Cancer resistance to complement-dependent cytotoxicity (CDC): problem-oriented research and development","volume":"46","author":"Gancz","year":"2009","journal-title":"Mol Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.it.2004.01.008","article-title":"Complement function in mAb-mediated cancer immunotherapy","volume":"25","author":"Gelderman","year":"2004","journal-title":"Trends Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1034\/j.1600-065X.2000.00612.x","article-title":"Bilevel control of B-cell activation by the inositol 5-phosphatase SHIP","volume":"176","author":"Brauweiler","year":"2000","journal-title":"Immunol Rev"},{"key":"B47","doi-asserted-by":"publisher","first-page":"10396","DOI":"10.1074\/jbc.272.16.10396","article-title":"Shc interaction with Src homology 2 domain containing inositol phosphatase (SHIP) in vivo requires the Shc-phosphotyrosine binding domain and two specific phosphotyrosines on SHIP","volume":"272","author":"Lamkin","year":"1997","journal-title":"J Biol Chem"},{"key":"B48","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1182\/blood-2002-04-1058","article-title":"SH2-containing inositol phosphatase (SHIP-1) transiently translocates to raft domains and modulates CD16-mediated cytotoxicity in human NK cells","volume":"100","author":"Galandrini","year":"2002","journal-title":"Blood"},{"key":"B49","doi-asserted-by":"publisher","first-page":"9099","DOI":"10.1158\/0008-5472.can-04-4424","article-title":"Src homology 2-containing inositol 5\u2019-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12","volume":"65","author":"Parihar","year":"2005","journal-title":"Cancer Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"eaam5353","DOI":"10.1126\/scisignal.aam5353","article-title":"Dual enhancement of T and NK cell function by pulsatile inhibition of SHIP1 improves antitumor immunity and survival","volume":"10","author":"Gumbleton","year":"2017","journal-title":"Sci Signal"},{"key":"B51","doi-asserted-by":"publisher","first-page":"26857","DOI":"10.1074\/jbc.272.43.26857","article-title":"Tyrosine phosphorylation and relocation of SHIP are integrin-mediated in thrombin-stimulated human blood platelets","volume":"272","author":"Giuriato","year":"1997","journal-title":"J Biol Chem"},{"key":"B52","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1074-7613(00)80187-9","article-title":"The RasGAP-binding protein p62dok is a mediator of inhibitory FcgammaRIIB signals in B cells","volume":"12","author":"Tamir","year":"2000","journal-title":"Immunity"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/hep.23168","article-title":"The beta2 integrin CD11b attenuates polyinosinic:polycytidylic acid-induced hepatitis by negatively regulating natural killer cell functions","volume":"50","author":"Zhang","year":"2009","journal-title":"Hepatology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01602\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T10:58:50Z","timestamp":1511175530000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01602\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,20]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2017.01602"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01602","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,20]]},"article-number":"1602"}}